Drägerwerk AG & Co. KGaA (DGWPF)
93.00
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Drägerwerk Cash from Operations (Quarterly) : -2.309M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.309M |
| March 31, 2026 | 72.54M |
| December 31, 2025 | 169.12M |
| September 30, 2025 | 88.05M |
| June 30, 2025 | -38.63M |
| March 31, 2025 | 58.85M |
| December 31, 2024 | 115.58M |
| September 30, 2024 | 68.92M |
| June 30, 2024 | -42.01M |
| March 31, 2024 | 36.40M |
| December 31, 2023 | 153.67M |
| September 30, 2023 | 58.86M |
| June 30, 2023 | -3.365M |
| March 31, 2023 | -4.541M |
| December 31, 2022 | 137.46M |
| September 30, 2022 | -64.58M |
| June 30, 2022 | -202.07M |
| March 31, 2022 | -28.00M |
| December 31, 2021 | 135.36M |
| September 30, 2021 | 110.99M |
| June 30, 2021 | 116.01M |
| March 31, 2021 | 91.63M |
| December 31, 2020 | 436.67M |
| September 30, 2020 | 69.92M |
| June 30, 2020 | -17.08M |
| Date | Value |
|---|---|
| March 31, 2020 | 54.41M |
| December 31, 2019 | 96.29M |
| September 30, 2019 | 51.30M |
| June 30, 2019 | 8.981M |
| March 31, 2019 | 26.47M |
| December 31, 2018 | 52.57M |
| September 30, 2018 | 28.78M |
| June 30, 2018 | -49.78M |
| March 31, 2018 | -30.63M |
| December 31, 2017 | 76.35M |
| September 30, 2017 | 55.52M |
| June 30, 2017 | 3.761M |
| March 31, 2017 | 29.64M |
| December 31, 2016 | 112.54M |
| September 30, 2016 | 53.57M |
| June 30, 2016 | 36.10M |
| March 31, 2016 | 11.48M |
| December 31, 2015 | 51.51M |
| September 30, 2015 | 65.85M |
| June 30, 2015 | -4.304M |
| March 31, 2015 | -70.33M |
| December 31, 2014 | 146.09M |
| September 30, 2014 | 59.02M |
| June 30, 2014 | 1.872M |
| March 31, 2014 | 34.41M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Ottobock SE & Co. KGaA | 53.52M |
| Abbott Laboratories | 2.488B |
| AngioDynamics, Inc. | 17.45M |
| Alphatec Holdings, Inc. | 20.51M |
| AtriCure, Inc. | 22.19M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -31.18M |
| Cash from Financing (Quarterly) | -50.42M |
| Free Cash Flow | 205.02M |
| Free Cash Flow Per Share (Quarterly) | -1.809 |
| Free Cash Flow to Equity (Quarterly) | -217.95M |
| Free Cash Flow to Firm (Quarterly) | -29.40M |
| Free Cash Flow Yield | 11.76% |